AI Atlas - Daily updates on real-world AI deployments worldwide

The Coldwater Board of Public Utilities (CBPU) in Michigan deployed eSmart Systems' Grid Vision AI platform for distribution grid inspection, signing a $248,000 five-year SaaS agreement after a 2024 pilot — now architected to scale to roughly 16,000 assets with no added headcount.

Visa's AI-driven fraud detection framework combines real-time threat monitoring, continuous ML model training, customizable rules engines, and AI-enhanced malware detection across its global payments network — balancing fraud prevention with seamless customer transactions.

JD.com has deployed more than 70,000 AI digital human sellers in live commerce, with the cost of digital-human streaming falling to one-tenth that of real human hosts and 2025 GMV reaching tens of billions of yuan, fundamentally changing the cost structure of live-stream selling operations across thousands of seller accounts on the platform.

LS ELECTRIC deployed generative AI in 2023 at its Cheongju factory in South Korea to power robotic arm quality inspection of circuit breakers and contactors, driving over-inspection rates from 10 percent to 0 percent and reaching an overall defect rate of 0.0007 percent.

An independent head-to-head study by Redgrave LLP tested Relativity aiR for Review against a traditional first-pass managed review workflow on approximately 45,000 documents from a real-world pharmaceutical marketing, controlled substances, and federal compliance data set, reporting time savings, accuracy metrics, and reviewer efficiency gains for legal e-discovery teams.

Bayer China built Dr. Bei, an LLM-based generative AI training system on AWS, to train pharmaceutical medical representatives. The system delivers intelligent dialogue and personalized evaluation for role-play coaching, saving 6,000-7,000 training hours per year and improving 1-on-1 role-play training efficiency by more than 50%. The system reached 1,000 medical representatives within 72 days of initiative launch.

Atlassians Rovo Dev code reviewer, an AI-driven pull request reviewer, improved developer productivity at Atlassian by 30.8%, measured by faster PR turnaround. The agent proactively catches quality, security, and performance issues early in the development cycle, complementing human reviewers and reducing rework across the engineering organization.

Autyn deployed LandingAI's agentic document-extraction platform to automate consumer-loan processing. Field-level accuracy rose to 94-98% on borrower documents (tax returns, paystubs, bank statements), reducing end-to-end income extraction from 1-2 hours to 1-3 minutes per file. The deployment has processed 500+ loan files and 3,000+ documents in production, saving loan officers 2-4 hours of manual work per file. Every extracted value carries a source tag and confidence score, routing low-signal fields to human review.

Zürcher Kantonalbank (ZKB), Switzerland largest cantonal bank, has deployed an AI-powered fraud detection platform using deep learning and behavioural biometrics, in partnership with NetGuardians since 2021. The system processes millions of daily transactions across retail, corporate, and securities trading, using graph neural networks, multi-scale temporal analysis, and a tiered decision framework (95% of transactions pass through lightweight models without delay) to detect deepfake fraud, social engineering, and account takeover attacks that rule-based systems miss.

Commerzbank has deployed Hawk AI's AML AI Extended Risk Model to enhance anti-money-laundering detection across payment operations. The AI model supplements Commerzbank's traditional rules-based monitoring by identifying complex patterns beyond static rules, with Commerzbank's Group CCO Hans-Georg Beyer and Cluster Lead Viktor Kraus both publicly endorsing the deployment. The deployment has delivered higher alert accuracy, fewer false positives, and detection of novel money laundering and fraud patterns.

Okara is an AI CMO that orchestrates eight specialized sub-agents (SEO, GEO, social, content, Reddit, Hacker News, and adjacent channels) to drive growth for over 120,000 small businesses, processing 4 billion tokens per day. Built by a 4-person Singapore-based team, the platform runs on Vercel AI Gateway (unified multi-provider inference with retry, fallback, zero-data retention) and Vercel Sandboxes (isolated agent execution), enabling same-day model availability and shipping 6-7x daily. New AI models become available to users the day they ship, and the SEO agent can scan a user's site, spin up a Sandbox to fix technical issues, and open a pull request — all with a human making the final call before anything goes live.

In October 2025 Eli Lilly and NVIDIA announced a strategic collaboration to deploy the world's first NVIDIA DGX SuperPOD with DGX B300 systems — an AI factory of 1,016 NVIDIA Blackwell Ultra GPUs delivering over 9,000 petaflops of AI performance, equivalent to ~7 million Cray supercomputers per GPU. The factory trains large biomedical foundation and frontier models for drug discovery, runs NVIDIA BioNeMo for molecular and antibody design, Omniverse digital twins of manufacturing lines, Isaac robotics in factories, NeMo-based AI agents in labs, and MONAI for imaging. Selected models are exposed externally via Lilly TuneLab, a federated-learning platform providing biotechs access to over USD 1 billion of Lilly's proprietary drug-discovery data, now also offering NVIDIA Clara open foundation models. The deployment is anchored by Lilly's USD 50B U.S. manufacturing and R&D expansion including the $4.5B Medicine Foundry in Indiana.

At ASCO 2026 (Abstract 3525, May 2026) Mayo Clinic presented a deep-learning study that quantifies tumor microenvironment (TME) features from digitized stage III colon cancer resection slides and links them to postoperative ctDNA status and patient outcomes in the phase III NCCTG N0147 trial cohort of 2,260-3,084 patients. The approach pairs an algorithm-derived digital pathology biomarker with the tissue-free Guardant Reveal ctDNA methylation assay (>98% specificity), creating a multimodal tissue+liquid-biopsy framework for residual-disease risk stratification. ctDNA-positive patients had 5-year DFS of 27.7% vs 77.1% for ctDNA-negative (HR ~5.0 for recurrence), and AI-quantified tumor budding, stroma, and TIL features correlated with ctDNA positivity and prognosis, supporting combined tissue+ctDNA biomarkers for adjuvant therapy decisions.

In May 2026 Bristol Myers Squibb announced a strategic partnership with Anthropic to deploy Claude Enterprise, Anthropic's agentic AI platform, and Claude Code across the entire global organization of more than 30,000 employees, spanning drug discovery, clinical development, manufacturing, and commercial operations. The deployment is built on more than three years of prior internal AI investments and is positioned as BMS's 'shared intelligence platform' for the next decade, with concrete use cases including generating clinical study reports from raw trial data, surfacing decades of proprietary scientific context, and tracing the root cause of manufacturing issues in real time. It is among the largest agentic-AI rollouts in pharma, alongside Merck's 75,000-employee Google Cloud Gemini deal.

Syneos Health expanded its AI ecosystem around the Kinetic commercial intelligence engine with strategic partnerships to KAI Conversations (used by 10 of top 20 global pharma), Sageforce's AI MSLs, and causaLens causal-AI data agents. The deployment delivers real-time field intelligence, hybrid human+AI medical-science-liaison teams, and causal reasoning for HCP targeting, engagement optimization, and territory design. Combined with the Mindset Engine (behavioral data from ~14,000 HCPs across 30+ specialties), Syneos is embedding AI into biopharma commercial workflows to accelerate HCP engagement and brand performance, including deployment for HelioLiver's nationwide rollout to gastroenterologists and hepatologists. Cross-reference: flagship 2026 customer is HelioLiver HCC rollout (use case 09106ea6…); Syneos's Kinetic + AI MSLs deploys that test's HCP engagement.

Helio Genomics developed HelioLiver, an AI-powered blood test that uses machine learning to integrate cfDNA methylation patterns, protein tumor markers (AFP, AFP-L3%, DCP), and patient demographics for early detection of hepatocellular carcinoma. In the 1,968-patient CLiMB prospective study it achieved roughly 4x greater sensitivity for Stage I liver cancer than ultrasound, with early-stage sensitivity of 75-85% versus ultrasound's ~47%. HelioLiver is now commercially available nationwide in the U.S. through Quest Diagnostics' 7,700+ patient service centers (Medicare-covered at $662/test, CPT 0333U) and a 2026 commercial partnership with Syneos Health is scaling adoption via the AI-driven Kinetic platform and hybrid human/AI MSL field force. Cross-reference: deployed via Syneos Health's Kinetic + AI MSLs (use case c0b22088…).

At Snowflake Summit 2026 (June 2026), Sanofi launched Concierge for Field, an agentic AI sales-support tool built on Snowflake's Cortex AI platform and the Elementum AI orchestration engine. Pharma sales reps use natural language to ask the agent for a pre-call plan; within seconds it identifies the highest-priority physicians in their territory by specialty, prescribing history, and prior engagement, then emails a tailored call plan. The system unifies Sanofi's structured and unstructured data in Snowflake's data cloud and is being scaled across thousands of reps globally, with Sanofi also extending the same agentic AI blueprint to R&D, procurement, IT, and HR.

Roche has deployed over 3,500 NVIDIA Blackwell GPUs (2,176 on-premises in US/EU plus cloud) to build an AI factory that powers Lab-in-the-Loop drug discovery, genomic analysis, and Omniverse-based digital twins of its new $2B Holly Springs, North Carolina GLP-1 manufacturing facility. The infrastructure uses BioNeMo for molecular design, Parabricks for genomic and pathology data, NeMo/Guardrails for safe generative AI, and Omniverse to simulate and optimize the next-generation obesity drug plant before construction, with industry reports citing 25-40% capacity gains and 15-20% lead-time reductions from digital-twin factories.

AXA Switzerland has deployed an AI-powered claims automation platform enabling straight-through processing for qualifying motor, property, and health insurance claims, with the most straightforward motor cases now settling within a single day rather than the multi-day traditional cycle. The platform combines computer vision damage assessment, OCR and NLP across German/French/Italian/English, and predictive analytics scoring every claim on five dimensions (complexity, expected cost, fraud risk, litigation probability, customer sensitivity). Overall claims processing costs have decreased meaningfully, with savings partially reinvested in expanded digital channels and human support for complex claims.

Microsoft has deployed more than 25 AI agents and applications inside its own global supply chain — spanning 70+ Azure regions, 400+ datacenters, 600,000+ km of fiber, plus Surface and Xbox hardware — and aims to operate 100+ agents by end of 2026. Named examples include the Demand Planning Agent, the Multi-Agent DC Spare-Part Space Solver, and the CargoPilot Agent.